ESC 365 - Doctor Neha Pagidipati

Speaker illustration

Doctor Neha Pagidipati

Duke Clinical Research Institute, Durham (United States of America)

Neha J. Pagidipati, MD MPH is an Assistant Professor of Medicine and cardiometabolic disease prevention specialist at the DCRI. Currently, her research focuses on implementation of evidence-based care of patients with high cardiovascular disease risk and diabetes, obesity, and/or lipid disorders. Clinically, she is building the Duke Cardiometabolic Prevention Program, which will focus on behavior change and risk factor management in patients at high risk of cardiovascular and metabolic diseases.

Panel discussion.

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists

Exploring the gap between data and clinical practice.

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists

Risk prediction for ASCVD in primary prevention patients on statin therapy

Event: ESC Congress 2019

Topic: Cardiovascular Risk Assessment

Session: New approaches in risk stratification

The association between obesity, diabetes control, and cardiovascular outcomes: insights from the TECOS trial

Event: ESC Congress 2017

Topic: Nutrition

Session: Impact of obesity on cardiovascular prognosis: new data

ESC 365 is supported by